TINTED SILICONE OPHTHALMIC DEVICES, PROCESSES AND POLYMERS USED IN THE PREPARATION OF SAME

• US 20090244479A1
• Filed: 03/20/2009
• Published: 10/01/2009
• Est. Priority Date: 03/31/2008
• Status: Abandoned Application

• Current Assignee: Johnson & Johnson Vision Care Incorporated (Johnson & Johnson)
• Original Assignee: Johnson & Johnson Vision Care Incorporated (Johnson & Johnson)
• Inventors: Reboul, Adam C., Sleenstrup, Frederik R., Palusak, Ryan David, Molock, Frank F. JR., Kindt-Larsen, Ture, Zanini, Diana, Spaulding, Terry L.
• Application Number:
  US12/408,327
• Publication Number:
  US 20090244479A1
• Time in Patent Office: Days
• US Class Current: 351/162
• CPC Class Codes: G02B 1/043 Contact lenses

Abstract

Tinted ophthalmic devices, methods for their production, and non-crosslinked binding polymers used in their production are disclosed herein.

Claims

1. A process comprising

(a) applying a first colorant composition comprising at least one non-crosslinked binding co-polymer, at least one pigment, dye or mixture thereof and at least one printing solvent to a surface of an ophthalmic device mold;

(b) adding up to an amount required to prepare an ophthalmic device, and over the non-crosslinked binding co-polymer of step (b), an uncured hydrogel formulation, wherein said hydrogel formulation, when cured, has a oxygen permeability of greater than about 50 barrer; and

(c) curing said hydrogel formulation to form a stable, tinted ophthalmic device.

2. The process of claim 1 wherein the non-crosslinked binding co-polymer comprises at least one oxygen permeability enhancing component.

3. The process of claim 2 wherein said at least one oxygen permeability enhancing component is selected from compounds of Formula I

where

R¹ is independently selected from monovalent reactive groups, monovalent alkyl groups, or monovalent aryl groups, any of the foregoing which may further comprise functionality selected from hydroxy, amino, oxa, carboxy, alkyl carboxy, alkoxy, amido, carbamate, carbonate, halogen or combinations thereof;

and monovalent siloxane chains comprising 1-100 Si—

O repeat units which may further comprise functionality selected from alkyl, hydroxy, amino, oxa, carboxy, alkyl carboxy, alkoxy, amido, carbamate, halogen or combinations thereof;

b=0 to 500, where it is understood that when b is other than 0, b is a distribution having a mode equal to a stated value;

at least one R¹ comprises a monovalent reactive group, and in some embodiments between one and 3 R¹ comprise monovalent reactive groups.

4. The process of claim 2 wherein the oxygen permeability enhancing component comprises 3-methacryloxypropyltris(trimethylsiloxy)silane, monomethacryloxypropyl terminated polydimethylsiloxanes, polydimethylsiloxanes, 3-methacrylxoypropylbis(trimethylsiloxy)methylsilane, methacryloxypropylpentamethyl disiloxane and combinations thereof

5. The process of claim 2 wherein the oxygen permeability enhancing component comprises mono-(3-methacryloxy-2-hydroxypropyloxy)propyl terminated, mono-butyl terminated polydimethylsiloxane.

6. The process of claim 1 wherein the non-crosslinked binding co-polymer comprises a monomer selected from the group consisting of N,N-dimethylacrylamide, 2-hydroxyethyl methacrylamide, 2-hydroxyethyl methacrylate propylethyleneglycol momomethyacrylate, methacrylic acid, acrylic acid, N-vinyl pyrrolidone, N-vinyl-N-methylacetamide, N-vinyl-N-ethyl acetamide, N-vinyl-N-ethyl formamide, n-vinyl formamide and mixtures thereof.

7. The process of claim 1 wherein the non-crosslinked binding co-polymer comprises monomers selected from the group consisting monomers of Formulae of II, IV, VI and VII:

and mixtures thereof.

8. The process of claim 1 wherein the non-crosslinked binding co-polymer comprises monomers selected from the group consisting of hydroxylethyl methacrylamide, N,N-dimethylacrylamide, N-vinyl pyrrolidone and mixtures thereof.

9. The process of claim 1 wherein step (a) is repeated using a second colorant composition.

10. The process of claim 9 wherein second colorant composition is different from said first colorant composition.

11. The process of claim 1 or 10 wherein at least one of the first or second colorant composition comprises at least one internal wetting agent.

12. The process of claim 11 wherein the internal wetting agent comprises polyvinylpyrrolidone having an average molecular weight of about 30 kD to about 1000 kD

13. The process of claim 11 wherein the internal wetting agent is selected from the group consisting of polyvinylpyrrolidone, poly-2-ethyl-2-oxazoline, poly(N,N-dimethylacrylamide), and polyvinyl alcohol.

14. The process of claim 11 wherein the internal wetting agent is polyvinylpyrrolidone.

15. The process of claim 1 wherein said binding polymer has a glass transition temperature of at least about 60°

C.

16. The process of claim 1 wherein said binding polymer has a glass transition temperature of at least about 70°

C.

17. The process of claim 1 wherein said binding polymer has a glass transition temperature of at least about 75°

C.

18. The process of claim 1 wherein said colorant composition further comprises at least one mid-boiling solvent.

19. The process of claim 18 wherein said mid-boiling solvent is selected from the group consisting of 1-ethoxy-2-propanol, 1,2-octanediol, 3-methyl-3-pentanol, 1-pentanol, methyl lactate, 1-methoxy-2-propanol, and mixtures thereof.

20. The process of claim 18 wherein said mid-boiling solvent comprises 1-ethoxy-2-propanol.

21. The process of claim 18 wherein said colorant composition further comprises at least one polar solvent.

22. The process of claim 21 wherein said at least one polar solvent is selected from the group consisting of methanol, ethanol, t-amyl alcohol, propanol, butanol and mixtures thereof.

39. The process of claims 1 or 23 wherein said hydrogel formulation is suitable for ophthalmic use without surface modification.

53. An ophthalmic device formed from the process of any of claims 1-10, 15-25 and 30-38.

54. The ophthalmic device of claim 53, wherein at least one of the colorless composition, the first or second coating composition comprises at least one internal wetting agent.

55. The ophthalmic device of claim 53 wherein the uncured hydrogel formulation is selected from the group consisting of galyfilcon, senofilcon, genfilcon, lenefilcon, comfilcon, acquafilcon, balafilcon, and lotrafilcon, and narafilcon.

56. The process of claim 1 or 23 further comprising the step of treating the mold after applying said colorant composition to at least partially remove volatile components.

23. A process comprising:

(a) applying a colorless coating composition comprising at least one non-crosslinked binding co-polymer and at least one printing solvent to at least one surface of an ophthalmic device mold,

(b) applying a first colorant composition comprising at least one non-crosslinked binding co-polymer, at least one pigment, dye or mixture thereof and at least one printing solvent over the colorless coating composition applied in step (a);

(c) adding, up to an amount required to prepare an ophthalmic device, and over the non-crosslinked binding co-polymer of step (b), an uncured hydrogel formulation, wherein said hydrogel formulation, when cured, has a oxygen permeability of greater than about 50 barrer; and

(d) curing said hydrogel formulation to form a stable tinted ophthalmic device.

24. The process of claim 23 wherein step (b) is repeated using a second colorant composition.

25. The process of claim 24 wherein second colorant composition is different from said first colorant composition.

26. The process of claims 123-24 wherein at least one of the colorless coating composition and the first and second coating composition comprises at least one internal wetting agent.

27. The process of claim 26 wherein the internal wetting agent is selected from the group consisting of polyvinylpyrrolidone, poly-2-ethyl-2-oxazoline, poly(N,N-dimethylacrylamide), and polyvinyl alcohol.

28. The process of claim 26 wherein the colorless coating composition and the first coating composition further comprise at least one internal wetting agent, which may be the same or different.

29. The process of claim 26 wherein the colorless coating composition and the first and second coating compositions further comprise at least one internal wetting agent, which may be the same or different.

30. The process of claim 26 wherein the internal wetting agent is polyvinylpyrrolidone.

31. The process of claim 23 wherein said at least one binding polymer has a glass transition temperature of at least about 60°

C.

32. The process of claim 23 wherein said at least one binding polymer has a glass transition temperature of at least about 70°

C.

33. The process of claim 23 wherein said at least one binding polymer has a glass transition temperature of at least about 75°

C.

34. The process of claim 23 wherein said colorant composition further comprises at least one mid-boiling solvent.

35. The process of claim 34 wherein said mid-boiling solvent is selected from the group consisting of 1-ethoxy-2-propanol, 1,2-octanediol, 3-methyl-3-pentanol, 1-pentanol, methyl lactate, 1-methoxy-2-propanol, and mixtures thereof.

36. The process of claim 34 wherein said mid-boiling solvent comprises 1-ethoxy-2-propanol.

37. The process of claim 34 wherein said colorant composition further comprises at least one polar solvent.

38. The process of claim 36 wherein said at least one polar solvent is selected from the group consisting of methanol, ethanol, t-amyl alcohol, propanol, butanol and mixtures thereof.

40. A composition for use in the production of stable tinted hydrogel ophthalmic devices having an oxygen transmissibility of greater than about 50 comprising at least one printing solvent, and at least one pigment, dye or mixture thereof and at least one non-crosslinked binding co-polymer formed from reaction of components comprising at least one oxygen permeable enhancing component.

41. The composition of claim 40 wherein the non-crosslinked binding co-polymer further comprises at least one traditional monomer.

42. The composition of claim 40 further comprising an internal wetting agent.

43. The composition of claim 40 having a viscosity of about 500 cps to about 2500 cps.

44. The composition of claim 41 wherein said at least one traditional monomer is selected from the group consisting of 2-hydroxyethyl methacrylate, hydroxylethyl methacrylamide, N,N-dimethylacrylamide, N-vinylpyrrolidone, and mixtures thereof.

45. The composition of claim 40 wherein said at least one oxygen permeability enhancing component is selected from the group consisting of 3-methacryloxypropyltris(trimethylsiloxy)silane, monomethacryloxypropyl terminated polydimethylsiloxanes, polydimethylsiloxanes, 3-methacrylxoypropylbis(trimethylsiloxy)methylsilane, methacryloxypropylpentamethyl disiloxane, mono-(3-methacryloxy-2-hydroxypropyloxy)propyl terminated, mono-butyl terminated polydimethylsiloxane, and mixtures thereof.

46. The composition of claim 40 wherein said at least one non-crosslinked binding copolymer has a glass transition temperature of at least about 60°

C.

47. A stable, tinted hydrogel ophthalmic device comprising a body formed of a silicone hydrogel having an oxygen transmissibility of greater than about 50 barrer/mm comprising at least one non-crosslinked binding co-polymer entangled at or near at least one surface of said silicone hydrogel.

48. The ophthalmic device of claim 47 wherein said non-crosslinked binding co-polymer comprises an internal wetting agent.

49. The ophthalmic device of claim 47 wherein said device is wettable.

50. The ophthalmic device of claim 47 wherein said device has an advancing dynamic contact angle of about 24 to about 90.

51. The ophthalmic device of claim 47 wherein said silicone hydrogel suitable for ophthalmic use without surface modification

52. The ophthalmic device of claim 47 wherein said at least one binding polymer has a glass transition temperature of at least about 60°

C.